Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexaminolevulinate PDT in Female Genital Erosive Lichen Planus
NCT01282515Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Aug 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hexaminolevulinate in lichen planus (LP), sponsored by Oslo University Hospital. Started Aug 2011; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
lichen planus (LP)
Beyond the preview
Go deeper on NCT01282515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01282515.